Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MDxHealth SAMDXH · Entity 7018 | Chief Commercial Officer | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MDxHealth SA
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.76 · Expires 2036-05-28 | Direct | 116,000 |
Reported balance
After 2026-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 116,000 · Balance 116,000 F1: Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026. The options vest upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods. |
| Share OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.76 · Expires 2036-05-28 | Direct | 217,000 |
Reported balance
After 2026-06-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-01 · Grant · Acquired 217,000 · Balance 217,000 F2: Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026 . The options vest in three equal installments on each of the first three anniversaries of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026. The options vest upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.
F2: Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026 . The options vest in three equal installments on each of the first three anniversaries of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 21:30 UTC | MDxHealth SA MDXH · Entity 7018 | GrantShare Option · Derivative | 217,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001193125-26-255809 · ownership.xml · derivative · entry 2 Bellano John · CIK 0001361085 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,000 Underlying: Ordinary Shares · 217,000 shares Expires 2036-05-28 F2 · derivative.exercise_date: Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026 . The options vest in three equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:30 UTC | MDxHealth SA MDXH · Entity 7018 | GrantShare Option · Derivative | 116,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001193125-26-255809 · ownership.xml · derivative · entry 1 Bellano John · CIK 0001361085 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,000 Underlying: Ordinary Shares · 116,000 shares Expires 2036-05-28 F1 · derivative.exercise_date: Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026. The options vest upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.